Immunocytochemical staining of ovarian tumours with Ov632

O J Owens, Owens OJ, F Mutch, Mutch F
Cytopathology : official journal of the British Society for Clinical Cytology · 1992 · doi:10.1111/j.1365-2303.1992.tb00042.x · PMID:1511121
other OA: closed public-domain-us
View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-13 ⓘ

Ov632 monoclonal antibody, reportedly specific for ovarian tumors, exhibited low sensitivity in staining ovarian tumor cells, with 13 of 41 samples showing negative results.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Ov632 monoclonal antibody, said to be highly specific for ovarian tumour tissue, was used to stain ovarian tumour cells in a variety of specimens to determine its sensitivity. Thirteen of the 41 samples investigated were negative suggesting a low sensitivity for Ov632.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Ovarian Neoplasms Adenocarcinoma Adenocarcinoma Antibodies, Monoclonal Ascites Ascites Biomarkers, Tumor Biomarkers, Tumor Breast Neoplasms Breast Neoplasms Cystadenocarcinoma Cystadenocarcinoma Cystadenoma Cystadenoma Endometriosis Endometriosis Female Humans Immunohistochemistry Immunohistochemistry

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-08-06T06:07:45.168820+00:00
pubmed
last seen: 2026-05-13T22:11:54.876058+00:00
unpaywall
last seen: 2026-05-14T19:30:52.867331+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine